Skip to main content
. Author manuscript; available in PMC: 2006 Jun 12.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2004 Nov;45(11):3863–3870. doi: 10.1167/iovs.04-0590

TABLE 1.

PCR Primers Used in this Study

Primer Exon Primer Sequence
GCAP1
4949 1S 5′-GGACTCAGGCCTGTGAGAGA
4950 1A 5′-CCAGCTGGTCAGGCTTCC
4951 2-4S 5′-CGGAGCCTTGGGTTATGAT
4952 2-4A 5′-GCGAGCTAAGCCTCTGAGTT
5094 2R* 5′-CCTCAGTCCCACATCCTGTC
5095 3F* 5′-TCTACTCCTCACTGCTCTTG
5097 4F* 5′-ACGTGGGCTCTGTCCCTGCC
GCAP2
5098 1S 5′-AGTCACCCAGGAGATGATGG
5099 1A 5′-ACGGAGTGGAAAGAAGAGCA
5100 2S 5′-GGCCACATGGATTAAAAGGA
5101 2A 5′-CACAGGAAACACACTCAGAATGA
5102 3S 5′-GTGATCCTAAGACGCACAGC
5103 3A 5′-TTCTCCACAGCCTTCTCACA
5104 4S 5′-TGAGGTCTGAGACTGCAGGA
5105 4A 5′-GAAGTCAACACCAGGGGAAGA

Exons terminating in an “S” are in the sense direction; those with “A” are in the antisense direction.

*

These primers were used for sequencing the PCR product amplified by 4951 and 4952.